CARLITTA HARRIS: Open Payments
NPI 1376191072 · SW, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 5 payments from 4 companies in 2025. Trend: 2023 $122 · 2024 $150 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $168 |
| Neurocrine BioSciences, Inc. | 1 | $117 |
| Alexion Pharmaceuticals, Inc. | 1 | $116 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $94 |
Products named: INGREZZA, STRENSIQ.
Industry payments across DC — which companies pay providers there.
